Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

RNA-seq Characterization of Melanoma Phenotype Switch in 3D Collagen after p38 MAPK Inhibitor Treatment

V. Čermák, A. Škarková, L. Merta, V. Kolomazníková, V. Palušová, S. Uldrijan, D. Rösel, J. Brábek

. 2021 ; 11 (3) : . [pub] 20210317

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025956

Melanoma phenotype plasticity underlies tumour dissemination and resistance to therapy, yet its regulation is incompletely understood. In vivo switching between a more differentiated, proliferative phenotype and a dedifferentiated, invasive phenotype is directed by the tumour microenvironment. We found that treatment of partially dedifferentiated, invasive A375M2 cells with two structurally unrelated p38 MAPK inhibitors, SB2021920 and BIRB796, induces a phenotype switch in 3D collagen, as documented by increased expression of melanocyte differentiation markers and a loss of invasive phenotype markers. The phenotype is accompanied by morphological change corresponding to amoeboid-mesenchymal transition. We performed RNA sequencing with an Illumina HiSeq platform to fully characterise transcriptome changes underlying the switch. Gene expression results obtained with RNA-seq were validated by comparing them with RT-qPCR. Transcriptomic data generated in the study will extend the present understanding of phenotype plasticity in melanoma and its contribution to invasion and metastasis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025956
003      
CZ-PrNML
005      
20220119144338.0
007      
ta
008      
211013s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom11030449 $2 doi
035    __
$a (PubMed)33802847
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Čermák, Vladimír $u Department of Cell Biology, Charles University, Viničná 7, 128 44 Prague, Czech Republic $u Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 252 42 Vestec u Prahy, Czech Republic
245    10
$a RNA-seq Characterization of Melanoma Phenotype Switch in 3D Collagen after p38 MAPK Inhibitor Treatment / $c V. Čermák, A. Škarková, L. Merta, V. Kolomazníková, V. Palušová, S. Uldrijan, D. Rösel, J. Brábek
520    9_
$a Melanoma phenotype plasticity underlies tumour dissemination and resistance to therapy, yet its regulation is incompletely understood. In vivo switching between a more differentiated, proliferative phenotype and a dedifferentiated, invasive phenotype is directed by the tumour microenvironment. We found that treatment of partially dedifferentiated, invasive A375M2 cells with two structurally unrelated p38 MAPK inhibitors, SB2021920 and BIRB796, induces a phenotype switch in 3D collagen, as documented by increased expression of melanocyte differentiation markers and a loss of invasive phenotype markers. The phenotype is accompanied by morphological change corresponding to amoeboid-mesenchymal transition. We performed RNA sequencing with an Illumina HiSeq platform to fully characterise transcriptome changes underlying the switch. Gene expression results obtained with RNA-seq were validated by comparing them with RT-qPCR. Transcriptomic data generated in the study will extend the present understanding of phenotype plasticity in melanoma and its contribution to invasion and metastasis.
650    _2
$a buněčná diferenciace $x účinky léků $x genetika $7 D002454
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x účinky léků $x genetika $7 D049109
650    _2
$a kolagen $x metabolismus $7 D003094
650    _2
$a stanovení celkové genové exprese $x metody $7 D020869
650    _2
$a regulace genové exprese u nádorů $x účinky léků $7 D015972
650    _2
$a genová ontologie $7 D063990
650    _2
$a lidé $7 D006801
650    _2
$a imidazoly $x farmakologie $7 D007093
650    _2
$a melanom $x genetika $x patologie $7 D008545
650    _2
$a naftaleny $x farmakologie $7 D009281
650    _2
$a fenotyp $7 D010641
650    _2
$a inhibitory proteinkinas $x farmakologie $7 D047428
650    _2
$a pyrazoly $x farmakologie $7 D011720
650    _2
$a pyridiny $x farmakologie $7 D011725
650    _2
$a sekvenování transkriptomu $x metody $7 D000081246
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a nádorové mikroprostředí $x účinky léků $x genetika $7 D059016
650    _2
$a mitogenem aktivované proteinkinasy p38 $x antagonisté a inhibitory $x metabolismus $7 D048051
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Škarková, Aneta $u Department of Cell Biology, Charles University, Viničná 7, 128 44 Prague, Czech Republic $u Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 252 42 Vestec u Prahy, Czech Republic
700    1_
$a Merta, Ladislav $u Department of Cell Biology, Charles University, Viničná 7, 128 44 Prague, Czech Republic $u Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 252 42 Vestec u Prahy, Czech Republic
700    1_
$a Kolomazníková, Veronika $u Department of Cell Biology, Charles University, Viničná 7, 128 44 Prague, Czech Republic $u Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 252 42 Vestec u Prahy, Czech Republic
700    1_
$a Palušová, Veronika $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, Pekařská 53, 656 91 Brno, Czech Republic
700    1_
$a Uldrijan, Stjepan $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital, Pekařská 53, 656 91 Brno, Czech Republic
700    1_
$a Rösel, Daniel $u Department of Cell Biology, Charles University, Viničná 7, 128 44 Prague, Czech Republic $u Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 252 42 Vestec u Prahy, Czech Republic
700    1_
$a Brábek, Jan, $u Department of Cell Biology, Charles University, Viničná 7, 128 44 Prague, Czech Republic $u Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (BIOCEV), Průmyslová 595, 252 42 Vestec u Prahy, Czech Republic $d 1973- $7 xx0268678
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 11, č. 3 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33802847 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20220119144335 $b ABA008
999    __
$a ok $b bmc $g 1714845 $s 1146463
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 3 $e 20210317 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace